EUVIMEDEUVIMED entdecken
Übersichtsarbeit

An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics

Miaomiao Sun, Xu Liu, Xiaohuan Sun, Jie Han iD

Chemistry – A European Journal · 2026

DOI: 10.1002/chem.71381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Miaomiao Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Key Laboratory of Green & Functional Materials and Environmental Chemistry, School of Chemistry and Materials, Yangzhou University…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit nennt 154 Literaturangaben. Gefördert von: National Natural Science Foundation of China, "333 Project" of Jiangsu Province, Yangzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cascade therapies have emerged as a paradigm‐shifting strategy against cancer, exploiting consecutive, self‐amplifying biochemical reactions to convert endogenous or externally supplied substrates into potent cytotoxic species. The marriage of this principle with nanotechnology has birthed “cascade nanotherapeutics”, which has proved augmented anticancer efficacy through integrating temporally coordinated catalytic, photonic, and redox activities within nanoscopic dimensions. In this review, we survey the most recent literature on cascade nanosystems for cancer therapy, proposing an intermediate‐centric view based on the pivotal small‐molecules or physicochemical signals that drive the antitumor cascades. These key intermediates include: (i) H 2 O 2 , (ii) O 2 , (iii) singlet oxygen ( 1 O 2 ), (iv) glutathione (GSH), and (v) localized hyperthermia, (vi) pH, and (vii) NO. For each category, we systematically discuss design principles and mechanistic underpinnings to establish fundamental structure‐activity relationships from a cascading perspective. Finally, we address unresolved challenges and outline future research outlook for next‐generation cascade nanotherapeutics with simple composition, adaptive intelligence, potent efficacy and clinical‐grade biosafety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsNanoparticlesHumansHydrogen PeroxideGlutathioneSinglet OxygenTumor MicroenvironmentNanomedicineOxidation-Reduction

Stichwörter der Autor:innen

cancer nanotherapycascade reactioncascade reaction intermediatetumor microenvironment

Substanzen

Antineoplastic AgentsHydrogen PeroxideGlutathioneSinglet Oxygen

Autor:innen und Institutionen

  • Jiangsu Provincial Key Laboratory of Green & Functional Materials and Environmental Chemistry, School of Chemistry and Materials, Yangzhou University, Yangzhou, Jiangsu, P. R. China.

ORCID-Profile: Jie Han

Förderung

  • National Natural Science Foundation of China
  • "333 Project" of Jiangsu Province
  • Yangzhou University
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • “333 Project” of Jiangsu Province

Zitieren

APA

Sun, M., Liu, X., Sun, X., & Han, J. (2026). An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics. Chemistry – A European Journal. https://doi.org/10.1002/chem.71381

Vancouver

Sun M, Liu X, Sun X, Han J. An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics. Chemistry – A European Journal. 2026. doi:10.1002/chem.71381

BibTeX
@article{Sun2026,
  author = {Sun, Miaomiao and Liu, Xu and Sun, Xiaohuan and Han, Jie},
  title = {An Intermediate‐Centric View of Cascade Cancer Nanotherapeutics},
  journal = {Chemistry – A European Journal},
  year = {2026},
  doi = {10.1002/chem.71381}
}
Kostenlos starten →